Clinical trial Recruiting at 2 sites Interventional Ages Any age to 7 Days

Optimal timing and treatment strategies for newborn complex congenital heart disease surgery

Official title: Multicenter Randomized Controlled Trial (RCT) and Efficacy Evaluation System Study on Surgical Innovation Strategies for Neonatal Complex Congenital Heart Disease

Run by Central China Fuwai Hospital of Zhengzhou University · NCT07363538 · Data updated 2026-11-12

This project will test whether doing heart surgery within the first week of life versus after day seven leads to fewer deaths and complications for newborns with complex congenital heart defects.

More Congenital Heart Disease trials

Quick facts

Study typeInterventional
AgesAny age to 7 Days
SexAll
Enrollment738 (estimated)
SponsorCentral China Fuwai Hospital of Zhengzhou University
Academic / other
Locations12 sites (Beijing, Beijing Municipality and 11 other locations)
StatusRecruiting
StartedDecember 1, 2025
Main results expectedJanuary 31, 2029
Study endsJanuary 31, 2029
Registry record updatedJanuary 23, 2026
Trial IDNCT07363538 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Term neonates (≥36 weeks gestation) weighing ≥2.5 kg who are diagnosed by pre-admission echocardiography with TAPVC, CoA/IAA, TGA, PA/IVS, or severe PS and whose families consent to one year of follow-up are ideal candidates.

Probably not a fit

Preterm infants (<36 weeks), low-birth-weight babies (<2.5 kg), those with severe extracardiac anomalies or very complex cardiac malformations, or neonates needing emergency unstable preoperative support are unlikely to benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a multicenter randomized controlled trial that will assign neonates with selected complex congenital heart defects to surgery either before day seven or after day seven of life. The trial builds on a national multicenter surgical database and a prenatal-postnatal integrated diagnosis and treatment model, and includes standardized perioperative protocols and one year of follow-up. The investigators will also develop comprehensive treatment strategies for critically ill neonatal patients and create an efficacy evaluation system based on trial data. The program intends to roll out the evaluation system nationwide to reduce perioperative mortality and non-recovery discharge rates.

Why it matters

Potential benefit: If successful, the approach could substantially lower perioperative deaths and non-recovery discharges and raise the overall standard of neonatal CCHD care in China.

How similar studies have gone: Randomized trials directly comparing neonatal cardiac surgery timing are limited and prior evidence is mixed, so this large multicenter RCT represents a relatively novel approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Neonates diagnosed with TAPVC, CoA/IAA, TGA, PA/IVS, or severe PS via pre-admission cardiac echocardiography;
2. Patients and families demonstrating high compliance, willing to sign informed consent forms and agree to complete one year of follow-up and related examinations.

Exclusion Criteria:

1. Preterm infant (gestational age \< 36 weeks at birth);
2. Low birth weight (weight \< 2.5 kg);
3. Concurrent severe extracardiac anomalies or complex cardiac malformations;
4. Preoperative respiratory or circulatory instability requiring emergency surgery.

Where it's running

  • Fuwai Hospital, Chinese Academy of Medical Sciences
    Beijing, Beijing Municipality, China
    Recruiting
  • Central China Fuwai Hospital of Zhengzhou University
    Zhengzhou, Henan, China
    Recruiting
  • Children's Hospital of Chongqing Medical University
    Chongqing, Chongqing Municipality, China
    Not yet recruiting
  • Guangzhou Women and Children's Medical Center, Guangzhou Medical University
    Guangzhou, Guangdong, China
    Not yet recruiting
  • Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
    Wuhan, Hubei, China
    Not yet recruiting
  • The Second Xiangya Hospital of Central South University
    Changsha, Hunan, China
    Not yet recruiting
Show 6 more locations
  • Children's Hospital Affiliated to Nanjing Medical University
    Nanjing, Jiangsu, China
    Not yet recruiting
  • Qingdao Women and Children's Hospital
    Qingdao, Shandong, China
    Not yet recruiting
  • Shanghai Children's Medical Center (SCMC) Affiliated to Shanghai Jiao Tong University School of Medicine
    Shanghai, Shanghai Municipality, China
    Not yet recruiting
  • The First Affiliated Hospital of Air Force Medical University (Xijing Hospital)
    Xi’an, Shanxi, China
    Not yet recruiting
  • West China Second Hospital of Sichuan University
    Chengdu, Sichuan, China
    Not yet recruiting
  • Children's Hospital Zhejiang University School of Medicine
    Hangzhou, Zhejiang, China
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.